Produção Nacional
Revisado por pares
Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease
2009; Wiley; Volume: 17; Issue: 2 Linguagem: Inglês
10.1111/j.1468-1331.2009.02863.x
ISSN1468-1331
AutoresMarco Antônio Araújo Leite, Osvaldo J. M. Nascimento,
Tópico(s)Cardiac Imaging and Diagnostics
ResumoEuropean Journal of NeurologyVolume 17, Issue 2 p. e9-e9 Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease M. A. A. Leite, M. A. A. Leite Federal Fluminense University (UFF), Department of Neurology, Niterói, Rio de Janeiro, BrazilSearch for more papers by this authorO. J. M. Nascimento, O. J. M. Nascimento Federal Fluminense University (UFF), Department of Neurology, Niterói, Rio de Janeiro, BrazilSearch for more papers by this author M. A. A. Leite, M. A. A. Leite Federal Fluminense University (UFF), Department of Neurology, Niterói, Rio de Janeiro, BrazilSearch for more papers by this authorO. J. M. Nascimento, O. J. M. Nascimento Federal Fluminense University (UFF), Department of Neurology, Niterói, Rio de Janeiro, BrazilSearch for more papers by this author First published: 13 January 2010 https://doi.org/10.1111/j.1468-1331.2009.02863.x Dr. Osvaldo J. M. Nascimento, MD, PhD, FAAN, Antônio Pedro University Hospital, CPG Neurologia, R. Marquês do Paraná 303, Niterói, Rio de Janeiro, Brazil CEP 24330-900 (tel.: +55 21 22354855; fax: +55 21 22354855; e-mail: [email protected]). Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Sawada H, Oeda T, Yamamoto K, et al. Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 2009; 16: 174–182. 10.1111/j.1468-1331.2008.02372.x CASPubMedWeb of Science®Google Scholar 2 Carrió I. Cardiac neurotransmission imaging. J Nucl Med 2001; 42: 1062–1076. CASPubMedWeb of Science®Google Scholar 3 Camacho V, Carrió I. Targeting neuronal dysfunction and receptor imaging. Curr Opin Biotechnol 2007; 18: 60–64. 10.1016/j.copbio.2007.01.002 CASPubMedWeb of Science®Google Scholar 4 Takahashi N, Anan F, Nakagawa M, et al. Microalbuminuria, cardiovascular autonomic dysfunction, and insulin resistance in patients with type 2 diabetes mellitus. Metabolism 2004; 53: 1359–1364. 10.1016/j.metabol.2004.03.024 CASPubMedWeb of Science®Google Scholar 5 Kiyono Y, Kajiyama S, Fujiwara H, et al. Influence of the polyol on norepinephrine transporter reduction in diabetic cardiac sympathetic nerves: implications for heterogeneous accumulation of MIBG. Eur J Nucl Med Mol Imaging 2005; 32: 438–442. 10.1007/s00259-004-1694-7 PubMedWeb of Science®Google Scholar 6 Diakakis GF, Parthenakis FI, Patrianakos AP, et al. Myocardial sympathetic innervation in patients with glucose tolerance: relationship to subclinical inflammation. Cardiovasc Pathol 2008; 17: 172–177. 10.1016/j.carpath.2007.07.007 CASPubMedWeb of Science®Google Scholar 7 Nascimento OJM, Azevedo J, Leite MAA, et al. Myocardial sympathetic innervation in patients with painful small fiber polyneuropathy with impaired glucose tolerance. Neurology 2009; 72(Suppl 3): A23–A24. Google Scholar Volume17, Issue2February 2010Pages e9-e9 ReferencesRelatedInformation
Referência(s)